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Abstract
The locus coeruleus (LC) is a key node of the sympathetic nervous system and suppresses 
parasympathetic activity that would otherwise increase heart rate variability. In the current study, 
we examined whether LC-MRI contrast reflecting neuromelanin accumulation in the LC was 
associated with high-frequency heart rate variability (HF-HRV), a measure reflecting 
parasympathetic influences on the heart. Recent evidence indicates that neuromelanin, a byproduct 
of catecholamine metabolism, accumulates in the LC through young and mid adulthood, 
suggesting that LC-MRI contrast may be a useful biomarker of individual differences in habitual 
LC activation. We found that, across younger and older adults, greater LC-MRI contrast was 
negatively associated with HF-HRV during fear conditioning and spatial detection tasks. This 
correlation was not accounted for by individual differences in age or anxiety. These findings 
indicate that individual differences in LC structure relate to key cardiovascular parameters.
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Introduction
Despite having its own pacemaker cells, the heart does not usually beat at a steady rate. 
Sympathetic and parasympathetic inputs from the brain modulate the timing of the heart’s 
sinoatrial node impulses and increase variability. These sympathetic and parasympathetic 
inputs have interacting and often opposing effects over heart rate variability (HRV), with 
parasympathetic input providing the dominant influence (Reyes del Paso, et al., 2013; 
Uijtdehaage and Thayer, 2000). Parasympathetic vagus nerve input influences both high- 
and low-frequency oscillations in heart rate, whereas sympathetic input directly influences 
only low-frequency oscillations (Berntson, et al., 1993; Laitio, et al., 2007), in part because 
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sympathetic influences on the heart are slower due to different neurokinetics compared with 
para-sympathetic influences (e.g., Saul, 1990).
HRV can be assessed in both the time and the frequency domains. Time domain indices of 
high-frequency variability such as the root mean square of successive differences (RMSSD) 
act as a high pass filter and thus reflect primarily parasympathetic influences. In the 
frequency domain, high-frequency HRV (HF-HRV) has been shown to correlate highly with 
activity of the vagus nerve and thus also reflects primarily parasympathetic influences on the 
heart (Kuo, et al., 2005). RMSSD and HF-HRV are highly correlated with each other and 
both can be used to index vagally-mediated HRV (Thayer, et al., 2010).
Recent neuroimaging work in humans has mapped out various ways in which individual 
differences in brain structure and function relate to HRV. A meta-analysis of this work 
showed that activations in the medial prefrontal cortex, anterior cingulate, putamen and 
amygdala were most consistently associated with HRV across studies (Thayer, et al., 2012). 
For instance, greater baseline RMSSD is associated with greater functional connectivity 
between amygdala and medial prefrontal cortex (Sakaki et al., 2016). Furthermore, across 
individuals, greater structural thickness in the anterior cingulate and prefrontal regions was 
associated with greater HF-HRV/RMSSD across several samples and among both younger 
and older adults (Winkelmann et al., 2016; Yoo et al., In preparation). These findings 
provide important insights into the cortical control of HF-HRV. However, evidence from 
patients and animal research indicate that various brainstem nuclei also exert key influences 
over HRV (George et al., 2004; Korpelainen, et al., 1996), and HRV has even been proposed 
as a way to assess brainstem function in order to discriminate between coma and brain death 
(Baillard et al., 2002; Schwarz, et al., 1987). Despite these linkages, little imaging work in 
healthy humans has addressed the relationships between brainstem and HRV, mainly due to 
the technical challenges of imaging small brainstem nuclei.
In the current study, we focus on the relationship between individual differences in HF-HRV 
and structure of the locus coeruleus, a brainstem nucleus that influences heart rate via 
multiple pathways. In addition to activating the sympathetic nervous system, LC activity 
inhibits parasympathetic cardiac vagal neurons (Wang, et al., 2014), including those in the 
dorsal motor nucleus of the vagus and the nucleus ambiguus, both vagal nuclei that influence 
heart rate (Samuels and Szabadi, 2008). Firing of these vagal nuclei reduces heart rate, 
whereas inhibiting them disrupts these reductions in heart rate (Samuels and Szabadi, 2008). 
Consistent with these LC noradrenergic suppressive influences over vagal nerve activity, 
administration of ß-adrenoceptor blocker drugs reduce heart rate and increase heart rate 
variability, effects that are attenuated when vagus nerve activity is blocked (Bittiner and 
Smith, 1986; for review see Grossman and Taylor, 2007).
In living humans, it has been difficult to obtain measures of LC structure, as it is small and 
has no visible markers on typical magnetic resonance imaging (MRI) scans. However, LC 
neurons contain neuromelanin, a pigmented polymer produced during oxidation of 
catecholamines, including norepinephrine in the LC (Wakamatsu et al., 2015). Recently 
developed MRI sequences optimize contrast for detecting neuromelanin and reveal the LC as 
bright white spots (Keren, et al., 2009; Shibata et al., 2006). Furthermore, by comparing the 
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LC with a nearby control region, the neuromelanin signal intensity can be measured, and 
this LC-MRI contrast measure has been corroborated in post-mortem brains by comparing it 
to histological analyses of neuromelanin in LC brain tissue (Keren et al., 2015). In-vivo 
scans of a group of adults between ages 23 and 80 suggest that, during early and middle 
adulthood, neuromelanin builds up in the LC, presumably reflecting the accumulated effects 
of catecholamine metabolism over time, but then show a decreasing trend in the 70’s 
(Shibata et al., 2006). The decreasing LC-MRI contrast values in late life are consistent with 
postmortem findings that the number of neuromelanin containing cells in the LC are lower 
in late life (German et al., 1988; Tomlinson, et al., 1981; Vijayashankar and Brody, 1979; 
Wree, et al., 1980). Thus, LC-MRI contrast provides a trait measure of LC structure that, 
based on hypothesized mechanisms of LC neuromelanin deposition (Wakamatsu et al., 
2015), should be influenced by previous levels of LC activity through young and mid 
adulthood, as well as by late-life LC structural integrity.
Insofar as LC activity suppresses parasympathetic influences that increase HF-HRV (Wang 
et al., 2014) and leads to catecholamine activity with neuromelanin as a byproduct 
(Wakamatsu et al., 2015), people with higher levels of LC activity on a daily basis should 
have both higher levels of neuromelanin and lower HF-HRV. In turn, in late life, loss of LC 
neuromelanin neurons should reduce LC suppression of parasympathetic influences. 
However, to our knowledge, no previous studies have examined the relationship between 
LC-MRI contrast and HRV. In the current study, we tested the prediction that higher levels 
of LC neuromelanin are associated with lower HF-HRV using electrocardiogram (ECG) 
derived measures of heart rate in both younger and older adults while they completed a 
couple of different tasks. These participants also completed structural MRI scans that 
included one targeting LC neuromelanin.
In this study we also examined and accounted for the role of age and trait anxiety in 
contributing to the relationship between LC-MRI contrast and HRV, as both aging and 
anxiety have been linked with the LC-NE system and HRV. For instance, in aging, LC 
structure changes (for review see Mather and Harley, 2016), and HRV declines (Bonnemeier 
et al., 2003; Lipsitz, et al., 1990; De Meersman and Stein, 2007; Umetani, et al., 1998). 
Likewise, anxiety has been linked with the LC-norepinephrine system (Redmond and 
Huang, 1979; Sullivan, et al., 1999; Tanaka, et al., 2000; Weiss et al., 1994) and is associated 
with lower HRV (for reviews see, Chalmers, et al., 2014; Friedman, 2007). We predicted that 
higher levels of LC-MRI neuromelanin contrast would be associated with lower HF-HRV 
even when controlling for age and trait anxiety. We used HF-HRV as our primary measure of 
vagally-mediated HRV. RMSSD and LF-HRV are included in the analyses to provide 
convergent and discriminant validity as RMSSD reflects primarily parasympathetic 
influences and so should yield similar results as HF-HRV, whereas LF-HRV reflects both 
sympathetic and parasympathetic influences and so is likely to show different results 
(Thayer et al., 2010).
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Methods
Participants
Participants in this study were drawn from a larger set of participants recruited to complete a 
study with both MRI and HRV measures (see Clewett et al., 2016). For the current study, we 
included all those who had both an LC-MRI contrast measure and measures of heart rate 
variability during the experimental task runs. This yielded 27 younger adults (M age=23.63 
years, SD=4.79, age range=18–34; 10 female) and 18 older adults (M age=67.89 years, 
SD=4.84, age range=60–75; 8 female). All participants were healthy, had normal or 
corrected-to-normal visual acuity, and were either students or community dwelling. Older 
adults were screened for dementia using the Telephone Instrument for Cognitive Status 
(TICS) over the phone before being scheduled (Brandt, et al., 1988), with a score of 31 or 
above required to participate. There were no significant differences between the two age 
groups in years of education (Myounger=16.3; Mo1der=16.5) or Wechsler Test of Adult 
Reading scores (Myounger=42.3; Mo1der=41.3). Participants provided written informed 
consent approved by the University of Southern California (USC) Institutional Review 
Board and were paid for their participation.
Procedure
Participants completed a series of structural and functional MRI scans acquired with a 3-T 
Siemans Magnetrom Trio scanner at the USC Dana & David Dornsife Cognitive 
Neuroscience Imaging Center. As part of this, a neuromelanin-sensitive-weighted MRI (LC-
MRI) scan was conducted using a T1-weighted fast spin-echo sequence (repetition time=750 
ms, echo time=12 ms, flip angle=120°, 11 axial slices, field of view=220 mm, 
bandwidth=220 Hz/Px, slice thickness=2.5 mm, slice gap=3.5 mm, in-plane 
resolution=0.429×0.429 mm2, and scan duration=1 min and 53 s).
Heart rate was measured using ECG during an initial fear-conditioning learning task (about 
6 min) and five task blocks of a spatial detection task (about 5 min for each block). For our 
main analyses, we averaged across the six different measurement occasions for each person, 
as aggregating across different measurement occasions increases the proportion of variance 
accounted for by trait rather than situation effects (Bertsch, et al., 2012). During the fear-
conditioning task, either a low- or high-pitched tone was paired with mild electric shock. 
Participants were presented with one of the CS tones for 0.7 s. A shock was delivered for 0.5 
s on half of the trials for the tone assigned to the CS+ condition. On the CS− tone trials there 
was no shock. During the spatial detection task, the CS+ or CS− tone played for 0.7 s, and 
then a place-object image pair appeared and participants were asked to identify the location 
of the salient image by pressing a left or right button. In each block, 16 CS+ trials and 16 CS
− trials (all 32 without associated shock) were randomly intermixed during this phase with 
three additional “booster” CS+ trials with shock.
Recording of heart rate
The experimenters attached electrodes to monitor participants’ heart rates. The ECG was 
obtained by a BIOPAC MP150 data acquisition system at the University of Southern 
California Dana and David Dornsife Neuroimaging Center. A LEAD108 setup with EL508 
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MRI-compatible/radio translucent electrodes was used for recording. The raw signal was 
amplified using an ECG100C amplifier. The signal was continuously digitized at a sampling 
rate of 10,000 Hz.
HRV analysis
The recorded data were analyzed with Acqknowledge software (BIOPAC Systems Inc., 
USA) for noise reduction. Because the ECG was recorded during MRI scanning, noise from 
the scanner can affect the ECG signal. Noise removal was performed through three steps. 
First, low pass filtering was applied at 40 Hz. Second, high pass filtering was applied at 0.5 
Hz. In the last step, a comb band stop was applied to filter out the noise frequency from the 
scanner. HRV calculations were performed on the corrected data using Kubios version 2.2 
(Tarvainen et al., 2014). Spectral analysis using a fast Fourier transform was used to 
generate the heart period power spectrum (Task-Force-of-the-European-Society-of-
Cardiology, 1996). The high frequency (HF) component (0.15–0.40 Hz) was used as our 
primary estimate of parasympathetic modulation. The root mean square of the successive 
difference (RMSSD) is a measure of rapid heart rate changes that, like HF-HRV, is 
predominantly vagally mediated (Sztajzel, 2004) and is used as another measure of 
parasympathetic influence over heart rate (e.g., Hansen, et al., 2003). Thus, to facilitate 
future cross-study comparisons we included it among our measures. We also included a 
measure of low frequency (LF) HRV (0.04–0.15 Hz) for comparison with HF-HRV. Six 
separate measures of each of these metrics were obtained for each subject from the six 
scans. To provide an index of individual differences we calculated the average HF-HRV, LF-
HRV and RMSSD across all scans for each participant that had sufficiently good quality 
recordings (as detailed below). HF-HRV and LF-HRV indices were natural log transformed 
prior to averaging because their distributions were highly skewed, which yielded normal 
distributions for all HF-HRV and LF-HRV indices used in analyses (including those 
conducted separately by age group), as assessed by one-sample Kolmogorov Smirnov tests. 
We excluded data from scans where all three of the following criteria were met: 1) The beat-
to-beat (RR) interval was below 500 ms and so was faster than would be expected (Umetani 
et al., 1998); 2) RMSSD was below 10, which would be more regular than expected for a 
normal heart rate (Umetani et al., 1998); 3) and the R peaks could not be identified via 
visual inspection, due to noise. In addition, we excluded all data from one scan that had an 
RMMSD more than 3 SD higher than the average RMMSD across all participant scans. 
Based on these criteria, 10 older adults had data from one or more of the six scans excluded 
(3, 2, 3, and 2 participants with 1, 2, 3, or 4 scans excluded, respectively) and eight younger 
adults had data excluded (3, 3, 1, and 1 participants with 1, 2, 3, or 4 scans excluded, 
respectively).
Anxiety questionnaire
Participants completed the 40-question State-Trait anxiety inventory (STAI; Spielberger, 
1983) before their MRI scan. We computed trait anxiety score from 20 of the questions.4
4As we were interested in examining the trait aspects of HRV rather than its situational influences, we focused on the trait component 
of the STAI, as well. However, results were highly similar if the state measure of the STAI were used. Older adults had lower state 
anxiety (M=27.0) than did younger adults (M=39.5), p<.001, and all reported correlations between trait anxiety and LC-MRI were 
similar in nature for state anxiety and LC-MRI.
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LC-MRI signal intensity
As outlined in Clewett et al., (2016), left and right LC regions of interest were hand-drawn 
on each participant’s LC-MRI image by two researchers who were blind to all other 
participant information. The intraclass correlations between ratings were .81 and .88, for 
right and left LC regions respectively. Left and right LC regions of interest (ROIs) were 
defined in the axial slice 7 mm below the inferior boundary of the inferior colliculus (e.g., 
Shibata et al., 2006) using a cross that was ~1.29 mm (or 3 voxels) wide and high to cover 
the 1–2mm distribution of LC neurons in this slice (German et al., 1988). The centers of 
these ROIs were manually placed on the left and right voxels with the highest signal 
intensity within locations anatomically consistent with the LC (Fig. 1). In cases in which the 
peak voxel was right next to the fourth ventricle, the center of the voxel was placed one 
voxel further away from the ventricle (such that the LC ROI still included the peak voxel) to 
avoid inclusion of ventricle voxels in the ROI, which could lead to underestimation of signal 
intensity. To control for scan differences in signal noise, a reference ROI was drawn in the 
dorsal pontine tegmentum (PT) using a 10×10 voxel square (18.4 mm2) equidistant between 
the left and right LC ROIs. To obtain our individual difference measure of LC-MRI contrast, 
we averaged the mean signal intensities from the left and right LC ROIs and used this 
average together with the PT value to compute the LC contrast-to-noise ratio using this 
formula: (LCintensity−PTintensity)/PTintensity (Sasaki et al., 2006; Shibata et al., 2006).
To examine associations between LC-MRI contrast and HRV we calculated Pearson 
correlations (we report the correlation 95% confidence intervals in brackets). The Fisher z-
test was used to calculate differences between correlations.
Results
Age group mean differences
Means and statistical comparisons across age groups for all variables assessed are shown in 
Table 1. As expected, older adults had significantly higher LC-MRI contrast than younger 
adults. In addition, older adults had significantly less HF-HRV power and more LF-HRV 
power than younger adults. RMSSD was marginally significantly greater among younger 
than older adults. Trait anxiety was significantly lower in older adults than in younger adults, 
consistent with declines in anxiety typically seen across middle adulthood (Gum, et al., 
2009; Teachman, 2006).
Individual differences in LC-MRI correlate with HF-HRV
For all correlation coefficients, we provide 95% confidence intervals in brackets. Across all 
participants, LC-MRI contrast correlated negatively with HF-HRV, r(43)=−.52 [−.71, −.27], 
p < .001 (Fig. 2), but did not correlate significantly with LF-HRV, r(43)=.13 [−.17, .41], p >.
3 (Table 2).5 The negative correlation with HF-HRV remained significant when age was 
included as a covariate, r(42)=−.45 [−.65, −.17], p=.002 (Table 3). Similar results were 
5For our main analyses, we used averages of HRV measurements across all scans in order to increase the trait stability of the measures 
(Bertsch et al., 2012). However, if we examined HRV from the fear conditioning session separately from the averaged HRV measures 
from the detection sessions, we found similar results across these two types of sessions, with significant correlations between HF-HRV 
and LC-MRI for both fear conditioning, r(35)=−.41, p=.01, and detection, r(43)=−.50, p < .001, significant correlations between 
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obtained for RMSSD as for HF-HRV. Likewise, including participant sex as a covariate did 
not change the nature of any of these correlations.
When each age group was considered separately, the correlation between LC-MRI and HF-
HRV did not quite attain significance for younger adults, r(25)=−.33, p=.098 (Table 4) but 
was significant for older adults, r(16)=−.64, p=.004 (Table 5). These correlations did not 
differ significantly from each other, Fisher’s z=1.26, p=0.21.
We note that if we included only those participants who only had clean HRV data from four 
or more scans (and thus were those for whom we could compute the most stable estimate of 
trait HRV), the correlation between HF-HRV and LC-MRI became significant for younger 
adults, r(23)=−.41 [−.69, −.02], p=04, and the other significant correlations between HF-
HRV and LC-MRI measures remained significant both at the whole group level and for older 
adults (see Supplementary Tables 1–4).
In summary, both younger and older adults showed a negative relationship between LC-MRI 
contrast and HF-HRV (although the relationship was stronger for older than for younger 
adults the correlations were not significantly different) and the negative correlation at the 
group level could not be accounted for by age differences in these variables.
As trait anxiety also differed across age groups and could potentially be a factor contributing 
to LC-MRI contrast, we also examined whether the correlation between LC-MRI contrast 
and HF-HRV could be accounted for by individual differences in trait anxiety. However, 
including trait anxiety as a covariate did not eliminate the negative correlation between LC-
MRI and HF-HRV, r(42)=−.49 [−.68, −.23], p=.001. There was a significant negative 
correlation between trait anxiety and LF-HRV at the group level, r(43)=−.34 [−.58, −.05], 
p=.02 (Table 2), that was no longer significant for the overall group when age was included 
as a covariate, r(42)=−.23 [−.49, .07], p=.13 (Table 3). This same correlation was significant 
within the older group, r(16) =−.48 [−.76, −.02], p=.04 (Table 5), although not when just 
those with 4 or more useable HRV estimates were included (Supplementary Table 4). Thus, 
there may be a weak relationship such that those with higher trait anxiety have lower LF-
HRV. However, trait anxiety was not significantly correlated with HF-HRV in either the 
whole group or within the age subgroups (all p > .1; see Tables 2, 4 and 5), and so is 
unlikely to be driving the relationships we found between HF-HRVand LC-MRI.
LC-MRI contrast and trait anxiety showed a weak negative relationship
As shown in Table 2, across all participants, there was a marginally significant correlation 
between LC-MRI contrast and trait anxiety. However, this correlation was no longer 
significant when age was included as a covariate (Table 3), and was not significant in either 
age group considered separately, nor after those with fewer HRV estimates were excluded 
(Supplementary Tables 1–4).
RMSSD and LC-MRI for both fear conditioning, r(35)=−.36, p=.03, and detection, r(43)=−.40, p=.006, and non-significant 
correlations between LF-HRV and LC-MRI for both fear conditioning, r(35)=.20, p=.2, and detection, r(43)=.10, p=.5. Thus, the 
negative correlations between HF-HRV/RMSSD and LC-MRI were consistent regardless of the task scan type during HRV 
measurement.
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Conclusions
LC activity influences HRV in part by inhibiting parasympathetic modulation of the heart 
(Samuels and Szabadi, 2008). Because, via the vagus nerve, parasympathetic inputs increase 
HF-HRV (Laitio et al., 2007), we predicted that individuals who have higher LC-MRI 
neuromelanin contrast should also have lower HF-HRV. Neuromelanin is a by-product of 
catecholamine activity (Wakamatsu et al., 2015). In the LC, it increases across young and 
mid-adulthood, then decreases in late life (Shibata et al., 2006), suggesting that 
neuromelanin may index habitual activation of the LC as well as its integrity in late life. We 
found that, across our cross-sectional sample that included younger and older adults, greater 
LC-MRI contrast was associated with lower HF-HRV during a couple of different tasks. 
This correlation is consistent with the LC’s role inhibiting parasympathetic modulation of 
the heart (Samuels and Szabadi, 2008).
Other recent findings in humans support the link between increased LC-NE system activity 
and decreased HF-HRV. In one study, inducing pain both increased LC activity and 
decreased HF-HRV (Sclocco et al., 2016). In another study (Bosch, et al., 2003), increases in 
salivary α-amylase (a marker of adrenergic activity; Granger, et al., 2007) were associated 
with decreases in RMSSD (which as mentioned is a measure of rapid heart rate changes that
—like HF-HRV—is predominantly vagally mediated; Sztajzel, 2004). Our study extends 
these findings and provides initial support for the notion that LC-MRI contrast provides a 
trait measure reflecting individual differences in LC-NE system activity. Furthermore, it is 
important to note that measures of HF-HRV even during tasks reflect primarily stable 
individual difference or trait variance particularly when several HF-HRV measures are 
aggregated as done in the present study (Bertsch et al., 2012). Thus, the present results 
suggest an association between trait levels of LC-NE system activity and trait levels of HF-
HRV.
With age, HRV decreases, especially in measures reflecting high frequency parasympathetic 
modulation such as RMSSD or HF-HRV (Bonnemeier et al., 2003; Lipsitz et al., 1990; De 
Meersman and Stein, 2007; Umetani et al., 1998). In addition, LC neuromelanin contrast 
increases across middle adulthood, leading to higher average LC neuromelanin contrast in 
those in their 60’s than those in their 20’s (Shibata et al., 2006). These expected age 
differences were seen within our sample. However, age did not account for the association 
between LC-MRI and HF-HRV, as even when age was included as a covariate, the 
correlation was significant. In addition, the negative correlations between LC-MRI contrast 
and HF-HRV did not appear to be driven by only one age group, as within each age 
subgroup, negative correlations were seen between LC-MRI contrast and HF-HRV.
These findings showing that LC-MRI neuromelanin contrast relates to parasympathetic 
system activity raise many interesting questions. One question is whether the similar 
relationships between these measures seen among younger and older adults might be driven 
by slightly different mechanisms. Among younger adults, LC-MRI neuromelanin contrast 
may reflect individual differences in the likelihood of activating LC, whereas among older 
adults LC-MRI neuromelanin contrast may also reflect the structural integrity of the LC (as 
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reviewed in the Introduction, the number of neuromelanin-containing neurons in the LC 
decrease in late life), and therefore the capacity for activating the LC.
Another question raised by these findings is whether the relationship is driven by individual 
differences in anxiety affecting both HF-HRV and LC activity. Although no significant 
relationships between trait anxiety and HF-HRV were seen in our sample of healthy adults 
(see also Dishman et al., 2000; Virtanen et al., 2003), people with anxiety disorders tend to 
have lower HRV (for reviews see Chalmers et al., 2014; Friedman, 2007). There are also 
links between anxiety and the noradrenergic system. One common characterization of 
anxiety disorders is that they are caused by noradrenergic system hyperactivation (e.g., 
Buoli, et al., 2013). Consistent with this, the α2-adrenergic agonist clonidine that inhibits 
synaptic noradrenaline release is one pharmacological treatment for anxiety (Hoehn-Saric, et 
al., 1981), and the α2-adrenergic antagonist yohimbine increases anxiety (Charney, 2003). 
However, despite these links between anxiety and α2-adrenergic pathways, the role of the 
LC in anxiety is not clear. One group reported that ablation of the LC in monkeys decreased 
behaviors associated with anxiety in humans (Redmond and Huang, 1979), but these 
findings were only reported in a meeting abstract and not replicated since to our knowledge.
In contrast with these findings, ablation of the LC in rodents leads to an increase in fear 
responses to novelty (Delini-Stula, et al., 1984; Koob, et al., 1984; Itoi and Sugimoto, 2010; 
Mason and Fibiger, 1979), or no change in social contacts during novelty (Crow, et al., 
1978), and increasing LC activation decreases anxious behavior in the open field test (Weiss 
et al., 1994). These findings suggest that LC activity may help reduce anxiety in at least 
some contexts. In our overall sample, LC-MRI contrast was marginally negatively correlated 
with trait anxiety and not significantly correlated when age was included as a covariate. 
However, if anxiety was a causal factor influencing both greater LC-MRI contrast and lower 
HF-HRV and leading the correlation between these variables, one would expect to see 
positive correlations between LC-MRI and anxiety, which were clearly not evident in our 
sample. Thus, it is unlikely that the relationships we found were due to individual 
differences in trait anxiety.
A related question for future research is what factors influence neuromelanin accumulation 
in the LC. To date, there has been little research on this topic. The links between LC and 
anxiety described above may have some bearing on this issue. Insofar as anxiety is 
associated with hyperactivated LC-NE system activity (e.g., Buoli et al., 2013), people 
suffering from higher trait anxiety should have on average higher tonic levels of LC activity, 
and therefore potentially higher long-term accumulation of neuromelanin in the LC. 
However, we did not see a positive relationship between anxiety and LC-MRI contrast; 
instead, trait anxiety showed a trend towards a negative correlation with LC-MRI contrast. 
This suggests that, at least within the range of anxiety experienced in a healthy sample, 
higher tonic levels of arousal induced by anxiety are not a particularly strong factor in 
increasing LC-MRI contrast. Instead, it may be the strength of the response of the LC-NE 
system to phasic arousing or engaging events that more strongly predicts individual 
differences in LC-MRI contrast. In studies stimulating the LC, burst stimulation yields more 
NE release per impulse than do evenly spaced stimuli (Aston-Jones, et al., 2010), which 
suggests the possibility that phasic LC responses stimulate more LC metabolism than tonic 
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activity, and so might be more important for determining long-term accumulation of 
neuromelanin.
Some strengths of this study are that it is the first study to examine the relationship between 
HRV and any measure of LC structure, that it aggregated across multiple measures of HRV 
increasing trait stability of the measure (Bertsch et al., 2012), and that it included both 
younger and older adults. One weakness is that we did not have a measure of HRV during a 
non-task resting state. Additional research is needed to examine whether the findings 
generalize to HRV collected during other types of contexts.
Our finding that greater LC-MRI neuromelanin contrast is associated with lower HF-HRV is 
intriguing and consistent with the notion that LC exerts an influence over HRV via its 
suppression of parasympathetic activity (Samuels and Szabadi, 2008). Furthermore, these 
results suggest that LC-MRI neuromelanin contrast measures provide a biomarker reflecting 
individual differences in the neural regulation of the heart. Further research is needed to 
investigate the build-up of neuromelanin in the LC across the life span and its relationship to 
other physiological and brain factors.
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Fig. 1. 
The steps used to delineate the LC regions of interest (ROIs). Step 1: In the axial plane, we 
identified the most inferior slice of the inferior colliculus (sagittal slices were also 
referenced to help identify the inferior-most portion of the inferior colliculus); Step 2: We 
then moved down 7 mm (2 slices) to a slice where LC should be most visible based on 
previous findings; Step 3: We drew a cross that was three voxels wide and three voxels tall 
and centered on the peak intensities of the left and right LC (each voxel was 0.429×0.429 
mm2); Step 4: Six voxels above the more ventral of the two LC ROIs and equidistantly 
between them, we drew a reference 10×10 voxel square ROI in the dorsal pontine 
tegmentum to allow us to normalize the LC based on noise in the image. Figure reprinted 
from Clewett et al. (2016).
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Fig. 2. 
The correlation between the locus coeruleus signal intensity based on the contrast-to-noise 
(CNR) ratio and high frequency heart rate variability (HRV) for younger adults (plotted 
using circles) and for older adults (plotted using squares).
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Table 1
Mean values of all measures by age group and t-tests comparing average values across age groups.
Measure Younger Adult Group Mean 
(and SD)
Older Adult Group Mean (and 
SD)
Independent Means T-test t and p values (df 
= 43)
LC-MRI Contrast 0.15 (.04) 0.18 (.05) t=−2.20, p=.03
HF-HRV 5.31 (.56) 4.77 (.57) t=3.14, p=.003
LF-HRV 5.76 (.46) 6.08 (.57) t=−2.09, p=.04
RMSSD 24.88 (4.73) 21.43 (6.73) t=2.02, p=.05
Trait Anxiety 36.19 (9.96) 27.00 (6.97) t=3.39, p=.002
Age 23.63 (4.79) 67.89 (4.84) t=−30.25, p<.001
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